RAPGEF3 and cancer: Accordingly, it is tempting to speculate that, by inhibiting ROS-dependent decrease in cell–cell contacts and increasing in cell permeability, Epac would maintain cell–cell based adhesion and provoke migration/metastasis in certain cancer types.